Journalists question safety and effectiveness of new Alzheimer’s drug
By
Kristen Fischer
Sep 26, 2024
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla (donanemab).
Promising results from Parkinson’s drug trial
By
Kristen Fischer
Sep 26, 2024
Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson’s disease and improved motor skills, the company reported on Thursday.
Study: Intervention for better delirium guideline adherence gives mixed results
By
Kristen Fischer
Sep 26, 2024
A new study assessed how well clinicians adhere to National Institute for Health and Care Excellence’s (NICE) delirium guidelines, and conducted an intervention that somewhat improved adherence.
Clinical briefs for Friday, Sept. 27
By
Kristen Fischer
Sep 26, 2024
Mutation linked to early-onset Parkinsonism, study finds … Older Americans Act set to expire … Study: Older adults with cancer have higher incidence of heart failure, myocardial infarction, stroke
Study: Amyloid beta differs based on ethnicity, cognitive ability stage
By
Kristen Fischer
Sep 25, 2024
A new study defined the ethnic differences of amyloid beta and cognitive trajectories in Koreans and non-Hispanic whites (NHWs).
Most patients expect antibiotics when they don’t need them, survey finds
By
Kristen Fischer
Sep 25, 2024
Most people expected to receive antibiotics for illnesses that were often caused by viruses, which don’t require them, according to survey results published Monday in the Annals of Family Medicine.
Report: People with dementia largely liked virtual programs during pandemic
By
Kristen Fischer
Sep 25, 2024
Virtual programs delivered during the pandemic were effective and useful for people living with dementia and their informal caregivers, a new study finds.
Clinical briefs for Thursday, Sept. 26
By
Kristen Fischer
Sep 25, 2024
Study: Model shows Parkinson’s progression … Grant to create brain-on-a-chip tech for Parkinson’s, dementia … Scientists spot molecules that could improve wound healing, study finds
Study shows how Parkinson’s drug may impair decision-making
By
Kristen Fischer
Sep 24, 2024
A new report sheds light on how a Parkinson’s disease drug may impair decision-making and lead to harmful behaviors like binge eating, gambling and compulsive shopping.
Study pinpoints multimorbidity prevalence in older adults
By
Kristen Fischer
Sep 24, 2024
Multiple factors go into the development and progression of multimorbidity — having two or more chronic diseases — in older adults. Higher levels of multimorbidity are associated with sociodemographic...